coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    St Helens South PCN, St. Helens (LAD) · Health Inequalities Profile

    PCN U94009 · NHS Cheshire and Merseyside Integrated Care Board · 10 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    87,308

    Registered population

    60.4% aged 18–64

    20.2%

    Aged 65+

    ICB 19.0% · England 17.9%

    4.0%

    Ethnic minority (non-White)

    1.8% Asian · England 9.6%

    42.9%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~39,044

    Core20 residents (est.)

    Resident basis; registered basis ~38,685 · see page 3

    15,893

    Hypertension register

    +5.90% in 3 yrs · England +5.60%

    1,078

    SMI register

    47.4% of St. Helens (LAD)'s

    2,462

    COPD register

    Reviews +9.31% in 3 yrs

    Forecast to 2030

    18,080

    Hypertension patients, 2030

    +2,187 on today

    74.6%

    QRISK ≥20% on statins, 2030

    +4.69pp over 3 yrs

    4.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    54.5%
    Annual asthma reviews lag behind England.

    Only 54.5% of the 6,668 asthma register had an annual review (England 65.7%, St. Helens 58.2%), leaving about 3,000 patients unreviewed.

    83.3%
    MMR coverage trails the 95.0% target.

    In Q1 2025/26, 24-month MMR1 is 83.3% (England 88.3%), and age-5 coverage differs by 7.4 pp between MMR1 (95.8%) and MMR2 (88.4%).

    74.0%
    Breast screening coverage exceeds all comparators.

    Breast screening for ages 53 to 70 reached 74.0% (St. Helens 73.1%, ICB 72.0%, England 69.9%), rising +10.8% over 2023 to 2024 (England +8.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ account for 20.2% of registrations, exceeding England while list growth lags

    Across 87,308 registered patients, 20.2% (17,608) are aged 65+, compared with 20.1% in St. Helens, 19.0% in the ICB and 17.9% in England, while children aged 0-17 comprise 19.5% (16,997). Projected list growth to 2030 is 1.3% under an unverified model, trailing St. Helens (1.6%), the ICB (2.3%) and England (2.3%). Based on resident Census data rather than GP registrations, 96.0% are White and 4.0% identify with ethnic minority groups (Asian 1.8%, Mixed 1.1%, Other 0.6%, Black 0.5%). This older profile may concentrate routine chronic disease management across primary care.

    Age profile

    0–1719.5%
    18–6460.4%
    65+20.2%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.0%
    Asian1.8%
    Mixed1.1%
    Other0.6%
    Black0.5%

    Older people · falls rows are St. Helens (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (St. Helens LA)2,2082,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (St. Helens LA)1,1431,0219552024/25
    Falls deaths, all ages, per 100,000 (St. Helens LA)24.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 42.9% across the PCN but varies sharply across member practices

    Across the PCN, 42.9% of registered patients live in Core20 areas, exceeding St. Helens (38.5%), the ICB (31.9%) and England (21.0%), with an average IMD decile of 4.3 (England 5.5). Weighted practice share is 44.3%, showing a 1.45 percentage point reconciliation discrepancy. Across captured practices, the Core20 cohort spans a range of 84.7 pp. Berrymead Family Med.ctr. records a Core20 share of 84.7%. Rainhill Village Surgery records a Core20 share of 0.0%. Estimated Core20 volume reaches 8,026 patients at Atlas Medical Practice. Targeting must balance high concentration against absolute volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Berrymead Family84.7% · 7,058 patients
    Atlas Medical70.8% · 8,026 patients
    Bowery59.4% · 3,060 patients
    Four Acre57.2% · 4,513 patients
    Rainbow52.2% · 7,759 patients
    Spinney Medical47.6% · 3,325 patients
    Mill Street41.2% · 4,163 patients
    Eccleston10.0% · 662 patients
    Longton1.3% · 119 patients
    Rainhill Village0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,078

    SMI register

    1.24% recorded prevalence

    593

    Learning disability register

    0.68% recorded prevalence

    32

    Care homes, 1,182 beds

    In the PCN catchment

    11.7%

    Provide unpaid care

    St. Helens (LAD), Census 2021

    The PCN records 1,078 severe mental illness patients (1.2%) and 593 with learning disabilities (0.7%), both above England (1.0% and 0.6%), alongside 32 catchment care homes (1,182 beds). St. Helens borough reports 20 rough sleepers in 2025 and an 11.7% unpaid care rate. Higher recorded prevalence across vulnerable registers highlights ongoing demand for routine health checks and coordinated care-home provision.

    Severe mental illness: physical health checks

    Across 1,078 SMI patients (1.2% prevalence), physical health checks trail England on BMI recording (75.0% vs 82.1%), alcohol consumption recording (74.1% vs 81.8%), and blood pressure checks (80.1% vs 83.4%). Addressing these checks could improve physical health monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    15,893

    Hypertension register

    +5.90%

    Register growth, 3 yrs

    St. Helens (LAD) +5.27% · England +5.60%

    +1.92pp

    BP control, under 80

    ≤140/90 · +0.08pp aged 80+

    +2,187

    More patients by 2030

    Forecast 18,080 (20.55%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.3% (15,893 patients), above England (15.2%) and the ICB (16.8%), though below St. Helens (18.7%). Crude rates are not age-adjusted. Blood pressure monitoring reached 87.5%, trailing England (90.0%), St. Helens (87.7%) and the ICB (88.3%). Furthermore, blood pressure control to 140/90 mmHg or less for patients aged under 80 is 65.5%, trailing England (67.8%), St. Helens (65.9%) and the ICB (66.4%). An unverified projection estimates 18,080 patients by 2030 (about 2,200 more). With blood pressure monitoring and under-80 control trailing national benchmarks across a large register, systematic recall audits could support improved blood pressure management.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reach 64.1%, exceeding England (63.6%), St. Helens (62.1%) and the ICB (63.2%). Statin coverage for diabetes with CVD is 83.8% (England 84.4%). With secondary statin coverage slightly below England, prioritising case reviews for diabetic patients with cardiovascular disease could help close secondary prevention gaps.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026181,583£2.00£1.71£1.86£363,166
    Cardiovascular (all), 2025266,155£4.16£4.37£3.33£1,107,205

    In 2026, the PCN prescribed 181,583 items for lipid-regulating drugs at £2.00 per item, compared with £1.86 in England, £1.75 in St. Helens, and £1.71 across the ICB. The PCN spends £25,422 more than at England's unit cost and £52,659 more than at ICB unit cost. Higher unit costs suggest potential to review prescribing choices against ICB formulary benchmarks.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.14%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.77%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 2.8% (2,462 patients; England 1.9%), and asthma prevalence is 8.2% (6,668 patients; England 6.6%). Annual COPD reviews reach 73.0% (England 76.4%). Annual asthma reviews reach 54.5% (England 65.7%), leaving about 3,000 patients unreviewed, while second-hand smoke status recording for ages 6-19 is 65.1% (England 78.8%). Paediatric asthma prescribing reaches 2,933 items per 1,000 aged 5-19 (England 1,488 rate). Expanding proactive asthma reviews could help evaluate care quality alongside elevated paediatric prescribing.

    Cancer register and children's immunisation

    The cancer register records 3,671 patients (4.2% prevalence vs 3.8% in England). In Q1 2025/26, 24-month MMR dose 1 coverage is 83.3% (England 88.3%, ICB 87.3%). At age 5, MMR dose 1 reaches 95.8% (England 91.7%) while MMR dose 2 is 88.4% (England 82.8%), reflecting a 7.4 pp same-cohort difference that reaches 15.5 pp at Rainbow Medical Centre. Auditing practice recall protocols may identify opportunities to improve second-dose completion before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months87.2%

    England 91.0%

    6-in-1 complete primary course at 24 months90.0%

    England 92.2%

    MMR dose 1 at 24 months83.3%

    England 88.3%

    MMR dose 2 at age 588.4%

    England 82.8%

    4-in-1 pre-school booster at age 585.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of staged cancers across NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2 (England 55.3%), rising 2.6 pp from 2013 to 2022 but 19.5 pp below the 75.0% national ambition by 2028. Closing this across the ICB requires about 2,640 extra early diagnoses annually across 13,490 cancers with a known stage (72.8%). For the PCN (3,671 cancer patients, 4.2% prevalence), cervical screening coverage is 67.3% (St. Helens 69.2%), down 1.1% over 2023 to 2025 (England -1.0%), with Atlas Medical Practice at 54.6% and The Bowery Medical Centre at 62.6%. Screening shortfalls at lower-uptake practices risk delayed diagnosis.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Mersey and West Lancashire Teaching Hospitals NHS Trust, 62-day referral to treatment performance is 7.0 pp below the 85.0% standard, while NHS Cheshire and Merseyside ICB is 8.8 pp below. On the 28-day faster diagnosis standard, the trust is 2.6 pp below the 75.0% standard, whereas the ICB is 2.2 pp above. On the 31-day combined treatment standard, the trust is 0.5 pp below the 96.0% standard and the ICB is 0.3 pp below. Secondary care treatment bottlenecks highlight the need for robust practice-level safety-netting and high-quality urgent referrals.

    Pathways within standard (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)72.3980.2175.4777.2579.32
    31-day treatment (96%)95.4698.1790.5195.7192.50
    62-day referral to treatment (85%)77.9683.6773.2676.2371.16
    Diagnostic waits over 6 weeks (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolEngland
    MRI14.040.536.4221.40
    CT13.082.320.719.92
    Echocardiography34.8828.0412.5528.48
    Colonoscopy18.0415.9833.1430.83
    Gastroscopy18.1720.2444.9929.02
    All 15 DM01 tests21.176.3411.5023.14
    Community services activitySt. Helens residentsCheshire and Merseyside ICB
    Care contacts48,525541,280
    Referrals7,81597,150
    Patients with a contact12,745146,240

    Community services (residents of St. Helens), Jun 2026 (provisional). In June 2026 (provisional), community services recorded 48,525 contacts with St. Helens borough residents, of which 29,090 were with adults aged 65 and over (a 59.9% share). High contact volume among older residents underscores the priority of coordinating community nursing and supportive cancer care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall patient satisfaction varies across a 24.6 percentage-point range between network practices

    In 2025/26, England recorded 97.1% achievement in the QOF clinical domain. Rainhill Village Surgery achieved 93.6%, and Atlas Medical Practice achieved 100.0%. In the QOF vaccination and immunisation domain, England recorded 55.2% achievement. Atlas Medical Practice achieved 15.6%, while Eccleston Medical Centre achieved 64.7%, reflecting a range of 49.0 pp between Atlas Medical Practice and Eccleston Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Rainhill Village1170.078.3%75.4%89.6%
    Eccleston11410.074.1%65.6%87.7%
    Mill Street12041.255.0%62.8%86.7%
    Longton1011.364.6%60.2%82.0%
    Spinney Medical11347.653.1%72.0%80.4%
    Rainbow12052.252.7%65.3%78.6%
    Berrymead Family11084.750.9%72.9%75.3%
    Four Acre10157.242.9%68.0%70.0%
    Bowery8459.457.5%82.3%67.1%
    Atlas Medical12070.842.3%79.5%64.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSt. Helens (LAD)AssetPCNSt. Helens (LAD)
    Care homes (catchment)32 (1,182 beds)n/aSchools (catchment)115n/a
    Children's centres78Places of worship6090
    Libraries915Primary schools (LA maintained)2832
    Primary academies811Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Proactive asthma review and prescribing recall

    Asthma annual reviews reach 54.5% across 6,668 patients (St. Helens 58.2%, ICB 62.3%, England 65.7%), leaving 3,035 (about 3,000) unreviewed, alongside 65.1% second-hand smoke recording (ages 6-19; England 78.8%). For discussion: standardise asthma review recall and inhaler checks, prioritising high-deprivation and high-volume practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Bundled SMI physical health check outreach

    Across 1,078 SMI patients (1.2% prevalence; 47.4% of the borough register), checks lag England on BMI (75.0% vs 82.1%), alcohol (74.1% vs 81.8%, falling 2.1 pp vs +5.4 pp), and BP (80.1% vs 83.4%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pre-school MMR and booster recall

    In Q1 2025/26, 24-month MMR1 is 83.3% (ICB 87.3%, England 88.3%), and age-5 MMR1 (95.8%) exceeds MMR2 (88.4%) by 7.4 pp across 216 children (15.5 pp at Rainbow Medical Centre). For discussion: audit pre-school immunisation call-recall lists, offer flexible slots, and focus catch-up on practices with widest dose gaps. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult chronic disease planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Differentiated Core20 outreach model (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI health check recall (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control recall audits (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake initiative (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Triage and phone access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Proactive asthma review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Bundled SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Pre-school MMR and booster recall (p12)MMR dose 1 coverage at 24 months · MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15